🚀 VC round data is live in beta, check it out!
Heren Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Heren Health and similar public comparables like Medley Inc., Veradigm, Weave Communications, Artrya and more.
Heren Health Overview
About Heren Health
Heren Health Co Ltd is an overall solution service provider focusing on research and development, sales, implementation integration and service support of medical information systems and digital scenario application systems. Its products includes electronic medical records, medical information integration platform, clinical data centers, clinical pathway system, integrated health care workstations and operation control system of medical institutions.
Founded
2010
HQ
Employees
541
Website
Financials (FY)
EV
$372M
Heren Health Financials
Heren Health reported last fiscal year revenue of $64M and EBITDA of $12M.
In the same fiscal year, Heren Health generated $30M in gross profit, $12M in EBITDA, and $7M in net income.
Heren Health P&L
In the most recent fiscal year, Heren Health reported revenue of $64M and EBITDA of $12M.
Heren Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $64M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $30M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 47% | XXX | XXX | XXX |
| EBITDA | — | XXX | $12M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 19% | XXX | XXX | XXX |
| Net Profit | — | XXX | $7M | XXX | XXX | XXX |
| Net Margin | — | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Heren Health Stock Performance
Heren Health has current market cap of $442M, and enterprise value of $372M.
Market Cap Evolution
Heren Health's stock price is $1.68.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $372M | $442M | 0.0% | XXX | XXX | XXX | $0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHeren Health Valuation Multiples
Heren Health trades at 5.8x EV/Revenue multiple, and 31.2x EV/EBITDA.
Heren Health Financial Valuation Multiples
As of April 20, 2026, Heren Health has market cap of $442M and EV of $372M.
Equity research analysts estimate Heren Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Heren Health has a P/E ratio of 63.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $442M | XXX | $442M | XXX | XXX | XXX |
| EV (current) | $372M | XXX | $372M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 5.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 31.2x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 30.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 12.5x | XXX | XXX | XXX |
| P/E | — | XXX | 63.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 30.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Heren Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Heren Health Margins & Growth Rates
Heren Health's revenue in the last fiscal year grew by 7%.
Heren Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Heren Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 5% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Heren Health Public Comps
See public comps and valuation multiples for other EHR & Practice Management and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Heren Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Medley Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| Veradigm | XXX | XXX | XXX | XXX | XXX | XXX |
| Weave Communications | XXX | XXX | XXX | XXX | XXX | XXX |
| Artrya | XXX | XXX | XXX | XXX | XXX | XXX |
| Beijing Sunwayworld | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Heren Health M&A Activity
Heren Health acquired XXX companies to date.
Last acquisition by Heren Health was on XXXXXXXX, XXXXX. Heren Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Heren Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHeren Health Investment Activity
Heren Health invested in XXX companies to date.
Heren Health made its latest investment on XXXXXXXX, XXXXX. Heren Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Heren Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Heren Health
| When was Heren Health founded? | Heren Health was founded in 2010. |
| Where is Heren Health headquartered? | Heren Health is headquartered in China. |
| How many employees does Heren Health have? | As of today, Heren Health has over 541 employees. |
| Is Heren Health publicly listed? | Yes, Heren Health is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Heren Health? | Heren Health trades under 300550 ticker. |
| When did Heren Health go public? | Heren Health went public in 2016. |
| Who are competitors of Heren Health? | Heren Health main competitors are Medley Inc., Veradigm, Weave Communications, Artrya. |
| What is the current market cap of Heren Health? | Heren Health's current market cap is $442M. |
| What is the current revenue of Heren Health? | Heren Health's last fiscal year revenue is $64M. |
| What is the current EV/Revenue multiple of Heren Health? | Current revenue multiple of Heren Health is 5.8x. |
| Is Heren Health profitable? | No, Heren Health is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.